top of page
Browse by category
Search
BMS surgery is safe and reduces the need for T2DM medication
Bariatric and metabolic surgery (BMS) is safe and induces substantial weight loss that reduces the need for T2DM medications, according...
DRI and W-DRI models accurately predict T2D remission post-BMS,
The Diabetes Remission Index (DRI) and Weight Loss-Adjusted Diabetes Remission Index (W-DRI) models – used to assess type 2 diabetes...
Adolescents who feel overweight face triple the risk of self-harm
Adolescents who perceive themselves as overweight are three times more likely to consider committing self-harm compared to those who do...
Response Pharmaceuticals completion enrolment of study evaluating RDX-002 post-GLP-1 weight rebound
Response Pharmaceuticals has completed enrolment in a Phase 2 trial evaluating the company’s drug candidate, RDX-002, for post-GLP-1...
Palatin completes Phase 2 obesity study with MC4R bremelanotide + Tirzepatide
Palatin Technologies has completed its Phase 2 BMT-801 clinical study of the co-administration of MC4R bremelanotide + GLP-1/GIP...
Wave Life Sciences initiates Phase 1 INLIGHT clinical trial of WVE-007 in obesity
Wave Life Sciences has announced clinical trial application (CTA) approval and initiation of the Phase 1 INLIGHT clinical trial of...
Browse by tag
bottom of page